Corticosteroids: Clinical Trials

18 trials of Corticosteroids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed. 18 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 218Completed 18
Phase 33Completed 3

Follow Corticosteroids: new trials by email Literature Review of Corticosteroids trials Research Report on Corticosteroids

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TCD601 in de Novo Renal Transplant Recipients
TCD601, belatacept, ATG - Renal Transplantation
Phase 2CompletedITB-Med LLC762023-12-282026-05-05
Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus
Lycopene Softgel, 10 Mg, Prednisolone - Erosive Lichen Planus
Phase 2 / Phase 3CompletedNourhan M.Aly202018-10-012020-12-03
Regimen Optimization Study
Thymoglobulin, Belatacept, mycophenolate mofetil(MMF) - Kidney Transplantation
Phase 2CompletedBristol-Myers Squibb582015-12-312021-06-22
A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma
LABA, corticosteroids, prednisolone - Asthma
Phase 2CompletedHoffmann-La Roche542013-07-012016-11-02
Optic Neuritis Recovery After Oral or IV Corticosteroids
corticosteroids - Optic Neuritis
Phase 2 / Phase 3CompletedLondon Health Sciences Centre512012-03-012015-09-02
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Simulect®, Neoral®, Certican® - Renal Transplantation
Phase 2CompletedNovartis Pharmaceuticals162012-03-012014-07-25
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Obinutuzumab, Corticosteroids - Lymphocytic Leukemia, Chronic
Phase 2CompletedGenentech, Inc.802011-10-312017-04-17
Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Ciclosporin, Prednisolone - Leprosy
Phase 2 / Phase 3CompletedLondon School of Hygiene and Tropical Medicine732010-08-012015-03-24
Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
prednisolone, ciclosporin - Leprosy
Phase 2CompletedLondon School of Hygiene and Tropical Medicine202010-08-012015-03-26
Ciclosporin in the Management of New Erythema Nodosum Leprosum
Ciclosporin, prednisolone - Leprosy
Phase 2CompletedLondon School of Hygiene and Tropical Medicine122010-07-012015-03-24
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)
Rituximab, Ciclosporine, Corticosteroids - Graft Versus Host Disease
Phase 2CompletedNantes University Hospital252010-06-012026-09-14
Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
Kidney Transplantation, Bone marrow transplantation, MEDI-507 - Kidney Transplantation, Kidney Failure, Chronic
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)52008-12-012015-11-10
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
Alefacept, tacrolimus, basiliximab - Kidney Transplantation
Phase 2CompletedAstellas Pharma Inc3232008-02-012015-12-11
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
calcineurin inhibitor-based immunosuppression, liver transplant, corticosteroids - Hepatitis C, Hepatitis C, Chronic
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2752005-10-012019-02-04
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis
methotrexate, rituximab, corticosteroids - Rheumatoid Arthritis
Phase 2CompletedGenentech, Inc.4652003-06-012013-05-09
Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney
Belatacept, Cyclosporine, Mycophenolate mofetil (MMF) - Graft Rejection, Kidney Transplantation
Phase 2CompletedBristol-Myers Squibb2302001-03-012014-01-13
Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
Rapamycin, Mycophenolate Mofetil, Tacrolimus - Type 1 Diabetes
Phase 2CompletedUniversity of Miami1702000-09-012017-07-12
Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients
Rapamune® (Sirolimus), Tacrolimus, Corticosteroids - Kidney Transplantation
Phase 2CompletedWyeth is now a wholly owned subsidiary of Pfizer1202000-04-012007-08-20

Conditions studied

Leprosy (3)  ·  Rejection, Psychology (2)  ·  Arthritis, Rheumatoid (1)  ·  Asthma (1)  ·  Demyelinating Diseases (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Graft vs Host Disease (1)  ·  Hepatitis (1)  ·  Hepatitis C (1)  ·  Hepatitis C, Chronic (1)  ·  Kidney Failure, Chronic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Liver Diseases (1)  ·  Multiple Sclerosis (1)  ·  Optic Neuritis (1)

Sponsors

London School of Hygiene and Tropical Medicine (3)  ·  Bristol-Myers Squibb (2)  ·  Genentech, Inc. (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Astellas Pharma Inc (1)  ·  Hoffmann-La Roche (1)  ·  ITB-Med LLC (1)  ·  London Health Sciences Centre (1)  ·  Nantes University Hospital (1)  ·  Nourhan M.Aly (1)  ·  Novartis Pharmaceuticals (1)  ·  University of Miami (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

United States (8)  ·  Ethiopia (3)  ·  France (2)  ·  Argentina (1)  ·  Canada (1)  ·  Egypt (1)  ·  United Kingdom (1)

Top investigators

Abraham Shaked, MD, PhD (1)  ·  Aliaa A Bedeir, BDS (1)  ·  Azza M Zaki, PhD (1)  ·  Ben Cosimi, MD (1)  ·  David Sachs, MD (1)  ·  Diana Lockwood, MBChB (1)  ·  Diana NJ Lockwood, MBChB (1)  ·  Diana NJ Lockwood, MBchB (1)  ·  Fredrik Juhlin (1)  ·  George W Burke, MD (1)

Results publications

PMID 12176626, PMID 12176628, PMID 15233820, PMID 18050221, PMID 22946986, PMID 23656665, PMID 26369526, PMID 26472752, PMID 28864814, PMID 29507942, PMID 30506630, PMID 30940770, PMID 33979314

NIH funding

2009 (1)